CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2013; 34(01): 34-37
DOI: 10.4103/0971-5851.113420
CASE REPORT

Case of childhood laryngeal papillomatosis with metastatic carcinoma esophagus in adulthood

Nishitha Shetty
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Kumar Prabhash
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Amit Joshi
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Suhail I. Sayed
Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Shilpi Sharma
Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Vanita Noronha
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Anuja Deshmukh
Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Devendra Chaukar
Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
S Kane
Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Gopal,
Anil K. D′cruz
Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
› Author Affiliations

Abstract

A young male patient was diagnosed to have laryngeal papillomas at the age of 3 years for which he underwent permanent tracheostomy and also multiple surgical and laser excision procedures. Then, later in life, the patient had progressive breathlessness and dysphagia. On examination, he had supraclavicular lymphadenopathy showing squamous carcinoma pathology. Since laryngeal papillomas have a high propensity to transform into laryngeal squamous cell carcinoma, he was first evaluated for laryngeal carcinoma which was negative. Esophagoscopy showed a growth in the esophagus, the biopsy of which was positive for squamous malignant cells. Patient was then started on palliative chemotherapy with combination of paclitaxel and carboplatin, and at progression with weekly nanoxel with stable disease. This is a rare case of childhood laryngeal papillomatosis progressing to metastatic esophageal carcinoma. This case has been presented to highlight the fact that patients with laryngeal papillomas are not only at high risk of progressing to laryngeal carcinoma but can also have other malignancies of the upper aerodigestive tract and lung. Most of them have been correlated to human papilloma virus (HPV), but in our patient HPV DNA was negative.



Publication History

Article published online:
20 July 2021

© 2013. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Schraff S, Derkay CS, Burke B, Lawson L. American society of pediatric otolaryngology members experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 2004;130:1039-42.
  • 2 Strong MS, Vaughan CW, Cooperband SR, Healy GB, Clemente M. Recurrent respiratory papillomatosis: Management with CO2 laser. Ann Otol 1976;85:508-16.
  • 3 Abramson AL, Steinberg BM, Winkler B. Laryngeal papillomatosis: Clinical, histopathologic and molecular studies. Laryngoscope 1987;97:678-85.
  • 4 Derkay CS. Task force on recurrent respiratory papillomas: A preliminary report. Arch Otolaryngol Head Neck Surg 1995;121:1386-91.
  • 5 Cohn AM, Kos JT, Taber LH, Adam E. Recurring laryngeal papilloma. Am J Otolaryngol 1981;2:129-32.
  • 6 Armstrong LR, Derkay CS, Reeves WC. Initial results from the National Registry for Juvenile-Onset Recurrent Respiratory Papillomatosis. Arch Otolaryngol Hea Neck Surg 1999;125:743-8.
  • 7 Louise L, Claassen A. HPV-induced recurrent laryngeal papillomatosis: Rationale for adjuvant fatty acid therapy. Asia Pac J Clin Nutr 2008;17:187-93.
  • 8 Donne AJ, Hampson L, Homer JJ, Hampson IN. The role of HPV type in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2010;74:7-14.
  • 9 Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: A review. Laryngoscope 2008;118:1236-47.
  • 10 Vambutas A, DiLorenzo TP, Steinberg BM. Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation. Cancer Res 1993;53:910-4.
  • 11 Lin HW, Richmon JD, Emerick KS, de Venecia RK, Zeitels SM, Faquin WC, et al. Malignant transformation of a highly aggressive human papillomavirus type 11-associated recurrent respiratory papillomatosis. Am J Otolaryngol 2010;31:291-6.
  • 12 Stephen JK, Chen KM, Shah V, Schweitzer VG, Gardner G, Benninger MS, et al. Consistent DNA hypermethylation patterns in laryngeal papillomas. Int J Head Neck Surg 2010;1:69-77.
  • 13 Katsenos S, Becker HD. Recurrent respiratory papillomatosis: A rare chronic disease, difficult to treat, with potential to lung cancer transformation: Apropos of two cases and a brief literature review. Case Resp Oncol 2011;4:162-71.
  • 14 Wierzbicka M, Jackowska J, Bartochowska A, Józefiak A, Szyfter W, Kêdzia W. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 2011;268:1305-11.
  • 15 Maturo S, Tse SM, Kinane TB, Hartnick CJ. Initial experience using propranolol as an adjunctive treatment in children with aggressive recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2011;120:17-20.
  • 16 Rabbett WF. Juvenile laryngeal papillomatosis: The relation of irradiation to malignant degeneration in this disease. Ann Otol Rhinol Laryngol 1965;74:1149-63.
  • 17 Majoros M, Devine KD, Parkhill EM. Malignant transformation of benign laryngeal papillomas in children after radiation therapy. Surg Clin North Am 1963;43:1049-61.
  • 18 Ilson DH, Wadleigh RG, Leichman LP, Kelsen DP. Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer. Ann Oncol 2007;18:898-902.
  • 19 Kato K, Tahara M, Hironaka S, Muro K, Takiuchi H, Hamamoto Y, et al. A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy. Cancer Chemother Pharmacol 2011;67:1265-72.